Stevens-Johnson Syndrome Antimicrobial

Stevens-Johnson Syndrome Clinical Trial

Official title:

Stevens-Johnson Syndrome Associated With Antimicrobial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00844038
• Other study ID #: SSJ1
• Secondary ID: 558187121279
• Status: Completed
• Phase: N/A
• First received: February 12, 2009
• Last updated: February 12, 2009
• Start date: August 2008
• Est. completion date: December 2008

Study information

• Verified date: February 2009
• Source: University of Pernambuco
• Contact: n/a
• Is FDA regulated: No
• Health authority: Brazil: Ethics Committee
• Study type: Observational

Clinical Trial Summary

Steven-Johnson's syndrome, or great multiform erythema, appears as a systemic disturbance, with skin involvement and mucous membranes, related to several factors, such as, viral or bacterial infections and mainly the administration of medicines, in general painkillers and antibiotics. The objective of this work is report the emergence of ulcerative vesicle -bubble chronic disease in areas of lips, gum, tongue and genital mucous membrane in a 26 year-old patient, leucoderma and masculine gender, in treatment of breathing infection with sulfametoxazol-trimetropima, having been diagnosed as syndrome of Steven-Johnson.

Description:

Among the serious medicaments reactions, there are as great representative the Mucocutaneous Disorders immunological mediated. Steven-Johnson's syndrome, or great multiform erythema, appears as a systemic disturbance, with skin involvement and mucous membranes, related to several factors, such as, viral or bacterial infections and mainly the administration of medicines, in general painkillers and antibiotics. The objective of this work is report the emergence of ulcerative vesicle -bubble chronic disease in areas of lips, gum, tongue and genital mucous membrane in a 26 year-old patient, leucoderma and masculine gender, in treatment of breathing infection with sulfametoxazol-trimetropima, having been diagnosed as syndrome of Steven-Johnson.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1
• Est. completion date: December 2008
• Est. primary completion date: August 2008
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 20 Years to 60 Years

Eligibility

Inclusion Criteria:

• Stevens-Johnson syndrome associated with antimicrobial

Exclusion Criteria:

• Not sick

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

• Stevens-Johnson Syndrome
• Syndrome

Locations

Country	Name	City	State
Brazil	University of Pernambuco	Recife	Pernambuco

Sponsors (1)

Lead Sponsor	Collaborator
University of Pernambuco

Country where clinical trial is conducted

Brazil, 

References & Publications (1)

Vanfleteren I, Van Gysel D, De Brandt C. Stevens-Johnson syndrome: a diagnostic challenge in the absence of skin lesions. Pediatr Dermatol. 2003 Jan-Feb;20(1):52-6. — View Citation